| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | Chief Executive Officer, Director | Voting Common Stock | 1,649,751 | $31,460,751 | $19.07 | 05 Feb 2026 | Direct |
| MapLight Therapeutics, Inc. | Chief Executive Officer, Director | Voting Common Stock | 101,190 | $1,929,693 | $19.07 | 05 Feb 2026 | Indirect |
| MapLight Therapeutics, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 93,955 | 05 Feb 2026 | Direct | ||
| MapLight Therapeutics, Inc. | Chief Executive Officer, Director | Series C Preferred Stock | 0 | 28 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 05 Feb 2026 | 2 | $0 | 4 | Chief Executive Officer, Director | 09 Feb 2026, 17:50 |
| MPLT | MapLight Therapeutics, Inc. | 27 Jan 2026 | 1 | -$3,670,545 | 4 | Chief Executive Officer, Director | 29 Jan 2026, 16:30 |
| MPLT | MapLight Therapeutics, Inc. | 27 Oct 2025 | 4 | $0 | 4 | Chief Executive Officer, Director | 28 Oct 2025, 16:15 |
| MPLT | MapLight Therapeutics, Inc. | 25 Oct 2025 | 0 | $0 | 3 | Chief Executive Officer, Director | 27 Oct 2025, 16:37 |